万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>医卫科学>>生物医学工程

生物医学研究杂志(英文版)(The Journal of Biomedical Research) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 CSCD核心(2025-2026), 维普收录, 万方收录, 知网收录,第一批认定学术期刊,外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

《生物医学研究杂志(英文版)》(The Journal of Biomedical Research)(双月刊)1987年创刊,为南京医科大学主办的综合性医药类期刊。接受国内外校友、专家和我校本部及附属医院、教学医院作者的论文。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、刊内网址:(202504期)

http://www.jbr-pub.org.cn

投稿系统:

https://mc03.manuscriptcentral.com/jbrint

3、刊内邮箱:jbr@njmu.edu.cn

4、刊内电话:025-86869291

5、出刊日期:双月刊,逢单月28日出版。

2025821日星期四

                          

 

Instructions for Authors

202501期信息】

 

Aim and Scope

Journal of Biomedical Research (JBR), a peer-reviewed open-access publication without any charges throughout the submission,review, and publication processes, intends to provide international biomedical investigators and clinicians with an open forum to disseminate important new information in all aspects of experimental and clinical medicine. The Journal is indexed by PubMed,Scopus, Web of ScienceTM Emerging Sources Citation Index (ESCI), Google Scholar, Chemical Abstracts, and CSCD-C, and welcomes submissions from authors worldwide. Six issues annually feature high-quality Original Articles, Review Articles (mainly invited), Case Reports, Letter to the Editor, and Perspectives. Manuscripts with clinical and public health implications and manuscripts with innovative ideas and/or approaches that bridge different fields are considered with priority.

General Requirements

All submitted manuscripts should contain original research that has not been previously published partly or in full in print or electronic format and is currently not under consideration for publication elsewhere. Manuscripts from any country are welcome but must be written in English. Original Articles should summarize results of a complete, rigorously designed study supported by experimental and/or clinical data with a thorough analysis. The recommended length for a full-length article is 3 000 to 5 000 words, excluding abstract, references, tables, or figures. Case Reports are intended to shed light on unusual cases and promote knowledge about unknown or novel disease processes or manifestations, which help contribute to a better understanding of such diseases, or provide up-to-date knowledge about rare and uncommon diseases. Submissions should not normally exceed 2 000 words or three published pages including figures, diagrams, and references. Letter to the Editor is usually written to report original data, comment on a current controversial issue or express the viewpoint of the writer, and it should be limited to 2 000 words. A single Figure or Table can be made but should contain no more than eight separate panels labeled from (a) to (h). One Figure may be composed of multiple panels with annotations around individual panels to make viewing easier. An abstract and subheadings should not be included in the Letters. All letters to the Editor are subject to editing and possible abridgment. Perspectives are intended to highlight recent, exciting research or discuss a timely topic. They usually do not discuss the author's own work in detail, but provide forward- looking and speculative thinking on the articles or hot topics being discussed. If there is experimental data presented to support the perspective, it is necessary to explain the data source. For example, if citing a figure from others, it is necessary to obtain consent from the original author and indicate the citation; if it is the result of the author's own unpublished article, it is necessary to indicate unpublished data. Perspectives should be no more than 2 000 words, with max 15 references and one figure or table. Editorial Commentary is usually written and commissioned by editors from JBR, which will summarize the current Special Issue or focus on commenting on the article published in the current issue.

Rapid Publication

The Journal offers rapid review and publication of studies that meet the following criteria: (a) Manuscripts with late-breaking research or immediate public health importance; (b) Manuscripts previously submitted to other reputable journals but not accepted for publication will be considered for rapid publication in JBR, if submitted with peer review comments and corresponding revisions. Manuscripts suitable for rapid publication will be processed in priority order.

If you intend to submit your manuscript through the Rapid Publication pathway, please state this in your cover letter. The editors will carefully consider your request through an internal review. However, it should be noted that approval for rapid publication does not guarantee acceptance of the manuscript. For those manuscripts that do not qualify for rapid publication, a standard review process will be conducted.

Details of Submission Requirements

A cover letter from the corresponding author must accompany the manuscript and should briefly describe what is known in the field, the conceptual advances provided by and the significance of the reported findings. The authors are encouraged to suggest appropriate reviewers and are permitted to make a request for the exclusion of up to three reviewers. The cover letter should state that the submitted material is original research, has not been previously published, and has not been submitted elsewhere while under review by JBR. For the materials (e.g., figures, diagrams, schemes, tables, and text), if any, reused/adapted from the works that have been published in both print and electronic formats elsewhere, written permission, if necessary, should be obtained from the copyright owner and submitted with the manuscript. The cover letter is confidential and will not be sent to the reviewers. The cover letter should contain the names of all the authors and their complete mailing addresses and identify the correspondence author.

......

更多详见刊内信息



  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭